|
GLMN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.0066948930596E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.12489994675525E-09 |
| Normal-vs-Stage2 |
4.235700E-04 |
| Normal-vs-Stage3 |
2.635303086862E-11 |
| Normal-vs-Stage4 |
1.66067160023431E-12 |
| Stage1-vs-Stage2 |
6.257200E-01 |
| Stage1-vs-Stage3 |
3.049600E-02 |
| Stage1-vs-Stage4 |
5.650299999993E-05 |
| Stage2-vs-Stage3 |
4.986300E-02 |
| Stage2-vs-Stage4 |
1.078180E-03 |
| Stage3-vs-Stage4 |
8.449800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.21169757455664E-11 |
| Normal-vs-AfricanAmerican |
8.17180000001194E-07 |
| Normal-vs-Asian |
2.00759999735567E-08 |
| Caucasian-vs-AfricanAmerican |
5.984200E-01 |
| Caucasian-vs-Asian |
9.742000E-01 |
| AfricanAmerican-vs-Asian |
5.703200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.08959999911562E-08 |
| Normal-vs-Female |
3.51340068149852E-11 |
| Male-vs-Female |
7.382000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.8035999944982E-08 |
| Normal-vs-Age(41-60Yrs) |
1.78660419791754E-11 |
| Normal-vs-Age(61-80Yrs) |
1.74780000472552E-08 |
| Normal-vs-Age(81-100Yrs) |
2.371400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.390200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.982000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.137600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.922000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.786600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.391800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.439530E-04 |
| Classical-VS-Follicular |
2.623100E-03 |
| Classical-VS-Other |
9.865800E-01 |
| Classical-VS-Normal |
1.00990005247326E-09 |
| Tall-VS-Follicular |
1.21859999979712E-07 |
| Tall-VS-Other |
5.481700E-02 |
| Tall-VS-Normal |
2.01338945515772E-12 |
| Follicular-VS-Other |
3.417600E-01 |
| Follicular-VS-Normal |
1.053750E-02 |
| Other-VS-Normal |
5.960400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.41210000546155E-08 |
| Normal-vs-N1 |
1.0251000048811E-09 |
| N0-vs-N1 |
1.941840E-02 |
|
|
